Sun Pharma ₹10,000 Crore NCD Issue: Down From ₹15,000 Cr
Sun Pharma's board approved up to ₹10,000 crore of NCDs, below the ₹15,000 crore proposed, and director Gautam Doshi resigned. What is known and unknown.
Sun Pharma's board approved up to ₹10,000 crore of NCDs, below the ₹15,000 crore proposed, and director Gautam Doshi resigned. What is known and unknown.